XML 45 R33.htm IDEA: XBRL DOCUMENT v3.25.3
Stockholders' Equity (Tables)
9 Months Ended
Sep. 30, 2025
Stockholders' Equity  
Schedule of common stock reserved for issuance, on an as-converted basis

    

September 30, 

    

December 31, 

2025

2024

Stock options issued and outstanding

 

20,090,359

 

9,458,788

RSUs issued and outstanding

2,670,905

Shares available for grant under the 2024 Equity Incentive Plan

930,301

6,893,517

Shares available for grant under the 2024 Employee Stock Purchase Plan

1,009,440

650,000

Shares available for grant under the ACELYRIN, Inc. 2023 Equity Incentive Plan

6,448,105

Shares available for grant under the 2024 Performance Option Plan

199,856

92,800

Total

 

31,348,966

 

17,095,105

Schedule of summarizes the activity for the company's restricted common stock

    

    

Weighted-

Average

Number of

Grant Date

Shares

Fair Value

Unvested as of December 31, 2024

 

2,583

$

2.90

Vested

 

(2,583)

$

2.90

Unvested as of September 30, 2025

 

$